Bulgaria vs Kazakhstan: Access to anti-retroviral drugs, female
Bulgaria
58.0%
in 2024
Kazakhstan
60.0%
in 2024
Bulgaria rank
105th
Kazakhstan rank
103rd
Access to anti-retroviral drugs, female over time
- Bulgaria
- Kazakhstan
How they compare
Kazakhstan currently reports 60.0% against 58.0% in Bulgaria, a difference of 2.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Bulgaria ahead.
Bulgaria ranks 105th and Kazakhstan ranks 103rd of 141 countries.
Across the 3 decades both report, Bulgaria averaged higher in 2 and Kazakhstan in 1.
Head to head by decade
| Decade | Bulgaria | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.9% | 1.3% | 13.6% | Bulgaria |
| 2010s | 38.4% | 21.3% | 17.1% | Bulgaria |
| 2020s | 53.4% | 54.0% | 0.6% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Bulgaria or Kazakhstan?
- Kazakhstan, at 60.0% against 58.0% in Bulgaria as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Bulgaria and Kazakhstan?
- 2.0%, with Kazakhstan ahead.
- How many years of comparable data are there for Bulgaria and Kazakhstan?
- 25 years are reported by both, from 2000 to 2024.
- How do Bulgaria and Kazakhstan rank globally for access to anti-retroviral drugs, female?
- Bulgaria ranks 105th and Kazakhstan ranks 103rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.